Carna Biosciences, Inc. (4572.T)
JPY 286.0
(2.14%)
JPY 286.0
(2.14%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -68.62 JPY | 30.76% |
| 2022 | -99.10 JPY | -135.39% |
| 2021 | -42.10 JPY | 53.39% |
| 2020 | -90.33 JPY | -218.78% |
| 2019 | 76.05 JPY | 160.83% |
| 2018 | -125.02 JPY | -59.2% |
| 2017 | -78.53 JPY | -148.2% |
| 2016 | -31.64 JPY | -160.14% |
| 2015 | 52.61 JPY | 151.49% |
| 2014 | -102.18 JPY | -179.26% |
| 2013 | -36.59 JPY | 50.07% |
| 2012 | -73.28 JPY | -18.96% |
| 2011 | -61.60 JPY | 8.93% |
| 2010 | -67.64 JPY | -15.15% |
| 2009 | -58.74 JPY | 40.15% |
| 2008 | -98.14 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -39.98 JPY | -71.81% |
| 2024 Q1 | -23.27 JPY | -614.82% |
| 2023 Q1 | -32.78 JPY | 18.8% |
| 2023 Q2 | -21.46 JPY | 34.53% |
| 2023 Q4 | 4.52 JPY | 122.45% |
| 2023 FY | - JPY | 30.76% |
| 2023 Q3 | -20.13 JPY | 6.2% |
| 2022 Q2 | -3.20 JPY | -185.71% |
| 2022 FY | - JPY | -135.39% |
| 2022 Q4 | -40.37 JPY | -896.79% |
| 2022 Q1 | -1.12 JPY | -118.3% |
| 2022 Q3 | -4.05 JPY | -26.56% |
| 2021 Q4 | 6.12 JPY | 118.9% |
| 2021 FY | - JPY | 53.39% |
| 2021 Q1 | -23.09 JPY | 38.0% |
| 2021 Q2 | -39.52 JPY | -71.16% |
| 2021 Q3 | -32.38 JPY | 18.07% |
| 2020 Q4 | -37.24 JPY | -83.54% |
| 2020 Q3 | -20.29 JPY | -15.09% |
| 2020 Q2 | -17.63 JPY | -15.61% |
| 2020 Q1 | -15.25 JPY | 38.38% |
| 2020 FY | - JPY | -218.78% |
| 2019 FY | - JPY | 160.83% |
| 2019 Q4 | -24.75 JPY | -261.31% |
| 2019 Q2 | 140.11 JPY | 704.97% |
| 2019 Q1 | -23.16 JPY | 40.46% |
| 2019 Q3 | -6.85 JPY | -104.89% |
| 2018 Q2 | -30.91 JPY | -51.82% |
| 2018 Q3 | -34.89 JPY | -12.88% |
| 2018 Q1 | -20.36 JPY | 15.06% |
| 2018 FY | - JPY | -59.2% |
| 2018 Q4 | -38.90 JPY | -11.49% |
| 2017 Q3 | -20.73 JPY | 2.72% |
| 2017 Q2 | -21.31 JPY | -66.48% |
| 2017 Q1 | -12.80 JPY | -5.96% |
| 2017 FY | - JPY | -148.2% |
| 2017 Q4 | -23.97 JPY | -15.63% |
| 2016 Q3 | -16.10 JPY | -549.19% |
| 2016 Q1 | -1.28 JPY | 90.18% |
| 2016 FY | - JPY | -160.14% |
| 2016 Q4 | -12.08 JPY | 24.97% |
| 2016 Q2 | -2.48 JPY | -93.75% |
| 2015 FY | - JPY | 151.49% |
| 2015 Q3 | -11.30 JPY | -116.43% |
| 2015 Q4 | -13.04 JPY | -15.4% |
| 2015 Q2 | 68.77 JPY | 508.58% |
| 2015 Q1 | 11.30 JPY | 120.59% |
| 2014 Q2 | -17.70 JPY | -31.11% |
| 2014 FY | - JPY | -179.26% |
| 2014 Q1 | -13.50 JPY | -28.69% |
| 2014 Q3 | -16.02 JPY | 9.49% |
| 2014 Q4 | -54.88 JPY | -242.57% |
| 2013 Q1 | -9.83 JPY | 28.46% |
| 2013 Q4 | -10.49 JPY | -71.13% |
| 2013 Q3 | -6.13 JPY | 43.86% |
| 2013 Q2 | -10.92 JPY | -11.09% |
| 2013 FY | - JPY | 50.07% |
| 2012 Q3 | -22.12 JPY | -20.68% |
| 2012 Q4 | -13.74 JPY | 37.88% |
| 2012 FY | - JPY | -18.96% |
| 2012 Q2 | -18.33 JPY | 7.98% |
| 2012 Q1 | -19.92 JPY | -122.32% |
| 2011 Q1 | -13.75 JPY | 20.06% |
| 2011 Q3 | -17.62 JPY | 17.2% |
| 2011 Q4 | -8.96 JPY | 49.15% |
| 2011 FY | - JPY | 8.93% |
| 2011 Q2 | -21.28 JPY | -54.76% |
| 2010 FY | - JPY | -15.15% |
| 2010 Q1 | -16.28 JPY | 31.19% |
| 2010 Q3 | -23.56 JPY | -122.47% |
| 2010 Q4 | -17.20 JPY | 26.99% |
| 2010 Q2 | -10.59 JPY | 34.95% |
| 2009 FY | - JPY | 40.15% |
| 2009 Q1 | -15.57 JPY | 0.0% |
| 2009 Q2 | -14.92 JPY | 4.17% |
| 2009 Q3 | -5.05 JPY | 66.15% |
| 2009 Q4 | -23.66 JPY | -368.51% |
| 2008 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 174.425% |
| PRISM BioLab Co.,LTD | -14.90 JPY | -360.537% |
| GNI Group Ltd. | 169.50 JPY | 140.484% |
| Linical Co., Ltd. | 14.98 JPY | 558.077% |
| Trans Genic Inc. | 0.24 JPY | 28691.667% |
| MEDINET Co., Ltd. | -6.65 JPY | -931.88% |
| Soiken Holdings Inc. | -25.32 JPY | -171.011% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | 543.568% |
| AnGes, Inc. | -39.29 JPY | -74.65% |
| OncoTherapy Science, Inc. | -6.05 JPY | -1034.215% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 21.28% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 442.244% |
| NanoCarrier Co., Ltd. | -11.10 JPY | -518.198% |
| CanBas Co., Ltd. | -67.87 JPY | -1.105% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | -168.466% |
| RaQualia Pharma Inc. | -14.98 JPY | -358.077% |
| Chiome Bioscience Inc. | -24.62 JPY | -178.716% |
| Kidswell Bio Corporation | -40.23 JPY | -70.569% |
| PeptiDream Inc. | 23.41 JPY | 393.123% |
| Oncolys BioPharma Inc. | -108.92 JPY | 37.0% |
| Ribomic Inc. | -28.70 JPY | -139.094% |
| SanBio Company Limited | -40.48 JPY | -69.516% |
| Healios K.K. | -56.22 JPY | -22.056% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | -276.826% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | -156.14% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 65.469% |
| StemRIM | -32.98 JPY | -108.065% |
| CellSource Co., Ltd. | 48.88 JPY | 240.385% |
| FunPep Company Limited | -39.63 JPY | -73.152% |
| Kringle Pharma, Inc. | -158.46 JPY | 56.696% |
| Stella Pharma Corporation | -24.66 JPY | -178.264% |
| TMS Co., Ltd. | -26.02 JPY | -163.72% |
| Noile-Immune Biotech Inc. | -27.25 JPY | -151.817% |
| Cuorips Inc. | -85.87 JPY | 20.089% |
| K Pharma,Inc. | 22.43 JPY | 405.93% |
| Takara Bio Inc. | 12.29 JPY | 658.34% |
| ReproCELL Incorporated | -0.37 JPY | -18445.946% |
| PhoenixBio Co., Ltd. | 6.88 JPY | 1097.384% |
| StemCell Institute Inc. | 30.25 JPY | 326.843% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | 2043.909% |
| CellSeed Inc. | -29.43 JPY | -133.163% |